Artisan Bio to highlight CRISPR platform at Cell & Gene Meeting

By The Science Advisory Board staff writers

October 11, 2021 -- Artisan Bio plans to highlight its CRISPR-engineered cell therapy platform at the Cell & Gene Meeting on the Mesa in Carlsbad, CA.

The company's STAR platform consists of a family of endonuclease-based editing systems to produce cell therapy design candidates. Artisan Bio has validated the platform with T cells, induced pluripotent stem cells and cancer cells, as well as industrial cell lines like CHO and HEK293, it said.

CRISPR-based method can speed the identification of disease-causing genes
A new CRISPR gene editing screening method can be used to link phenotype and genotype in animal models. The method was efficiently deployed in zebrafish...

Copyright © 2021

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter